UHMS-approved for severe thermal burns to reduce infection and improve graft survival. Early initiation (within 24 hours) critical.
HBOT Hub — http://localhost:3003/conditions/burns · Printed October 11, 2026 · UHMS approved · Acute care · Early intervention
GRADE Evidence Rating
Quality: LowWeak recommendation
Cochrane 2004 found insufficient high-quality RCT evidence. UHMS approval rests on burn-centre observational experience.
Overview
HBOT for severe thermal burns is a UHMS-approved indication. Treatment aims to reduce burn progression, limit tissue loss in the "zone of stasis," decrease infection, and improve skin graft survival. Must be initiated within 24 hours of injury for maximum benefit.
How HBOT Works
HBOT in burns reduces oedema via mild vasoconstriction, enhances tissue oxygenation of the zone of stasis, promotes angiogenesis for repair, improves neutrophil-mediated bacterial killing, and supports skin graft take. Reduction in fluid resuscitation requirements has been documented in some studies.
Clinical Protocol
Typical protocol
20–40 sessions at 2.0–2.4 ATA; early initiation critical
Evidence level
Moderate — UHMS approved
FDA / regulatory status
FDA-approved indication
Standard burn HBOT: 2.0–2.4 ATA sessions started within 24 hours of injury. Initial frequency may be twice daily for the first 48 hours, then daily. Total course 20–40 sessions depending on burn severity and surgical course. Coordinated with burn surgery team.
Cautions & Considerations
Early initiation (within 24 hours) critical for maximum benefit.
Requires coordination with burn surgery team.
Burn patients often require ventilator support — multiplace chamber capability needed.